Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Urgent interventional therapies / / edited by Nicholas Kipshidze [and four others] ; assistant editor, Cathy Kennedy ; foreword by Martin B. Leon
| Urgent interventional therapies / / edited by Nicholas Kipshidze [and four others] ; assistant editor, Cathy Kennedy ; foreword by Martin B. Leon |
| Pubbl/distr/stampa | Chichester, West Sussex, United Kingdom : , : John Wiley & Sons Limited, , 2015 |
| Descrizione fisica | 1 online resource (595 p.) |
| Disciplina | 616.02/8 |
| Soggetto topico |
Critical care medicine
Critical care |
| ISBN |
1-118-50449-6
1-118-50451-8 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Urgent Interventional Therapies; Copyright; Contents; List of Contributors; Foreword; Preface; List of Abbreviations; About the Companion Website; Part 1 Cardiac Interventions; Section I: Acute Coronary Syndrome; Chapter 1 Acute Coronary Syndrome: Guidelines and Definitions; Introduction; Definitions; Pathophysiology; Therapeutic strategies; Other considerations; References; Chapter 2 Cardiac Biomarkers in Acute Cardiac Care; Introduction; Markers of endothelial dysfunction; Biomarkers of vascular inflammation; Biomarkers of myocardial ischemia; Biomarkers of plaque destabilization
Biomarkers of plaque rupture Biomarkers of myocardial injury; Biomarkers of myocardial stretch or dysfunction; Summary; References; Chapter 3 Diagnosis of Vulnerable Plaque; Introduction; Coronary angiography; Intravascular ultrasound; Coronary angioscopy; Near-infrared spectroscopy; Optical coherence tomography; Intravascular thermography; Interventional treatment of vulnerable plaques; Conclusion; Summary; References; Chapter 4 Management of Thrombotic Disorders: Heparin to Newer Anticoagulants; Introduction and overview; Low molecular weight heparins; Ultra-low molecular weight heparins Antithrombin agents Factor Xa inhibitors; Generic antithrombotic drugs; Newer oral anticoagulants versus heparins; Some unanswered questions regarding the new oral anticoagulants; Summary; Future perspectives; References; Chapter 5 Newer Antiplatelet Agents for Interventional Indications; Introduction; Clopidogrel; Prasugrel; Ticagrelor; Conclusion; References; Chapter 6 Genetic Considerations of Antiplatelet Therapy; Introduction; General considerations; Specific genetic considerations; Therapeutic strategies; Practical recommendations; References Chapter 7 Anticoagulant Management of Heparin-Compromised Patients Introduction; Heparin; Anticoagulant alternatives to heparin; Summary; References; Chapter 8 Management of Bleeding in Urgent Interventions; Introduction; Incidence of bleeding; Risks associated with increased bleeding; Long-term outcomes; Mechanical and other contributors to bleeding; Measures to reduce the incidence of bleeding; Treatment of bleeding; New potential agents for the reversal of anticoagulation; References; Chapter 9 Role of Newer Anti-Xa and Anti-IIa Agents for Interventions; Introduction Percutaneous coronary intervention New anti-IIa and anti-Xa agents; New anticoagulants for cardiac interventional procedures; Conclusion; Summary; References; Chapter 10 Treatment of NSTEMI Patients; Introduction; Presentation and diagnosis; Antiplatelet therapies; Anticoagulation strategies; Invasive versus medical therapy; Conclusion; References; Chapter 11 Treatment of Patients with STEMI; Introduction; Indication; Literature review; Invasive treatment center; Technique of primary PCI; Summary; References Chapter 12 Mechanical Removal of Thrombus from Culprit Lesions: Current Devices and Future Developments |
| Record Nr. | UNINA-9910132337303321 |
| Chichester, West Sussex, United Kingdom : , : John Wiley & Sons Limited, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Urgent interventional therapies / / edited by Nicholas Kipshidze [and four others] ; assistant editor, Cathy Kennedy ; foreword by Martin B. Leon
| Urgent interventional therapies / / edited by Nicholas Kipshidze [and four others] ; assistant editor, Cathy Kennedy ; foreword by Martin B. Leon |
| Pubbl/distr/stampa | Chichester, West Sussex, United Kingdom : , : John Wiley & Sons Limited, , 2015 |
| Descrizione fisica | 1 online resource (595 p.) |
| Disciplina | 616.02/8 |
| Soggetto topico |
Critical care medicine
Critical care |
| ISBN |
1-118-50449-6
1-118-50451-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Urgent Interventional Therapies; Copyright; Contents; List of Contributors; Foreword; Preface; List of Abbreviations; About the Companion Website; Part 1 Cardiac Interventions; Section I: Acute Coronary Syndrome; Chapter 1 Acute Coronary Syndrome: Guidelines and Definitions; Introduction; Definitions; Pathophysiology; Therapeutic strategies; Other considerations; References; Chapter 2 Cardiac Biomarkers in Acute Cardiac Care; Introduction; Markers of endothelial dysfunction; Biomarkers of vascular inflammation; Biomarkers of myocardial ischemia; Biomarkers of plaque destabilization
Biomarkers of plaque rupture Biomarkers of myocardial injury; Biomarkers of myocardial stretch or dysfunction; Summary; References; Chapter 3 Diagnosis of Vulnerable Plaque; Introduction; Coronary angiography; Intravascular ultrasound; Coronary angioscopy; Near-infrared spectroscopy; Optical coherence tomography; Intravascular thermography; Interventional treatment of vulnerable plaques; Conclusion; Summary; References; Chapter 4 Management of Thrombotic Disorders: Heparin to Newer Anticoagulants; Introduction and overview; Low molecular weight heparins; Ultra-low molecular weight heparins Antithrombin agents Factor Xa inhibitors; Generic antithrombotic drugs; Newer oral anticoagulants versus heparins; Some unanswered questions regarding the new oral anticoagulants; Summary; Future perspectives; References; Chapter 5 Newer Antiplatelet Agents for Interventional Indications; Introduction; Clopidogrel; Prasugrel; Ticagrelor; Conclusion; References; Chapter 6 Genetic Considerations of Antiplatelet Therapy; Introduction; General considerations; Specific genetic considerations; Therapeutic strategies; Practical recommendations; References Chapter 7 Anticoagulant Management of Heparin-Compromised Patients Introduction; Heparin; Anticoagulant alternatives to heparin; Summary; References; Chapter 8 Management of Bleeding in Urgent Interventions; Introduction; Incidence of bleeding; Risks associated with increased bleeding; Long-term outcomes; Mechanical and other contributors to bleeding; Measures to reduce the incidence of bleeding; Treatment of bleeding; New potential agents for the reversal of anticoagulation; References; Chapter 9 Role of Newer Anti-Xa and Anti-IIa Agents for Interventions; Introduction Percutaneous coronary intervention New anti-IIa and anti-Xa agents; New anticoagulants for cardiac interventional procedures; Conclusion; Summary; References; Chapter 10 Treatment of NSTEMI Patients; Introduction; Presentation and diagnosis; Antiplatelet therapies; Anticoagulation strategies; Invasive versus medical therapy; Conclusion; References; Chapter 11 Treatment of Patients with STEMI; Introduction; Indication; Literature review; Invasive treatment center; Technique of primary PCI; Summary; References Chapter 12 Mechanical Removal of Thrombus from Culprit Lesions: Current Devices and Future Developments |
| Record Nr. | UNINA-9910820529903321 |
| Chichester, West Sussex, United Kingdom : , : John Wiley & Sons Limited, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||